MedTrace Logo

Exploring Biological Markers of Driver Fatigue for Enhanced Road Safety

NCT07089342 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 511

Last updated 2026-03-25

No results posted yet for this study

Summary

The aim of this study is to assess the effectiveness of biological markers in detecting fatigue/sleepiness in a sample of the general driving population in Belgium. The link between the collected biomarkers (oral fluid sample), observed signs of sleepiness in the driver and self-reported driver variables will be analysed. The analysis of the biological samples aims to measure endogenous metabolite levels that are possibly indicative for sleepiness of the donor driver. The respective metabolites will be chosen based on the results of a preceding clinical study (https://clinicaltrials.gov/study/NCT05585515). The objective of this study is to verify and validate the proposed metabolites as biomarkers for driver sleepiness in road traffic.

Conditions

Sponsors & Collaborators

  • Vias Institute Brussel

    collaborator UNKNOWN

  • Nationaal Instituut voor Criminalistiek en Criminologie Brussel

    collaborator UNKNOWN

  • University of Zurich

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-29
Primary Completion
2025-12-19
Completion
2025-12-19

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07089342 on ClinicalTrials.gov